loading...| Preferred Name |
belatacept |
|
| Synonyms |
|
|
| ID |
http://purl.obolibrary.org/obo/dinto_DB06681 |
|
| AHFScode |
92:44 |
|
| ATCCode |
L04AA28 |
|
| CASRN |
706808-37-9 |
|
| DBBrand |
nulojix |
|
| DBSynonym |
lea29y bms-224818 |
|
| Definition |
Belatacept is a recombinant fusion protein composed of the Fc fragment of a human IgG1 immunoglobulin linked to the extracellular domain of CTLA-4, which is a molecule crucial for T-cell costimulation. Belatacept selectively blocks the process of T-cell activation. It was developed by Bristol-Myers-Squibb. It differs from abatacept (Orencia) by only 2 amino acids. FDA approved on June 15, 2011. |
|
| label |
belatacept |
|
| may interact with |
http://purl.obolibrary.org/obo/dinto_DB08879 http://purl.obolibrary.org/obo/CHEBI_8764 |
|
| prefixIRI |
obo2:dinto_DB06681 |
|
| prefLabel |
belatacept |
|
| related with | ||
| xref |
National Drug Code Directory:0003-0371-13 Wikipedia:http://en.wikipedia.org/wiki/Belatacept RxList:http://www.rxlist.com/nulojix-drug.htm Drugs.com:http://www.drugs.com/cdi/belatacept.html |
|
| subClassOf |